Municipal Waste and Produced Water Update
GFL’s halted sale process sets a $52 to $58 per-share range, while its Secure acquisition could redirect investor attention toward produced-water operators such as WaterBridge.
GFL’s halted sale process sets a $52 to $58 per-share range, while its Secure acquisition could redirect investor attention toward produced-water operators such as WaterBridge.
@evfcfaddict @alluvialcapital $BWEL will work eventually
Tom likes the stock. $MKL adding >10% buyback auth, now ~15% buyback auth outstanding.
Target Posts Strongest Sales Growth in Years as Focus on New Products, Value Pays Off $TGT
TJX Raises Full-Year Outlook, Expects Sales Trends to Accelerate Through Holiday Season $TJX
Cal-Maine Foods to Cull 1.76 Million Birds After Florida Facility Tests Positive for Bird Flu $CALM
Lowe’s Sales Rise, as Professional Customers Drive Growth $LOW
CDW CEO Chris Leahy says AI adoption has reached a make-or-break phase as customers seek trusted guidance amid proliferating IT choices.
Realty Income trades near $58, with 2026 AFFO guidance of $4.45 to $4.46 per share and a 5.5% dividend yield supported by a low-70% payout…
S&P Global’s valuation swung from 7x earnings in 2009 to 50x in 2024 as ratings, indices and proprietary data expanded through acquisitions…
Amneal Pharmaceuticals posted its fourth straight earnings beat, with Q3 revenue up 10%, raised FY26 guidance and an expanding biosimilar…
Monte Investments rotated Nvidia into Alphabet before earnings and reviews Knife River’s margin squeeze, AMD’s World Labs acquisition, and…
Elanco’s earnings inflection and prospective dividend support targeted low-double-digit EPS growth despite Zoetis discounting.
Bruce Flatt’s Brookfield built 19 percent annual returns by buying distressed real assets below replacement cost with long-term…
Forestar trades near $22 versus $37.56 in tangible book value, with $657 million of cash and a potential D.R.
Entravision’s AdTech revenue rose 133% and EBIT 261% in Q3 as management weighs TV-station sales before its TelevisaUnivision agreement…
Steve Eisman, Dan Ives and Gil Luria assess how the midterms could reshape AI data-center spending, Google search growth, and competition…
CUE · short Cue Biopharma faces a deteriorating balance sheet, recurring operating losses, ATM dilution and PIPE-investor selling pressure.
Every publication on this site, hand-picked.
Every account on this site, hand-picked.
Ordered by how often our editor reaches for them.